Which company manufactures Sunlenca?

Sunlenca (Sunlenca) is an innovative long-acting anti-HIV drug developed and produced by Gilead Sciences Inc., an American biopharmaceutical company. Founded in 1987, Gilead is a pioneer in the field of global antiviral drugs. It has developed a variety of drugs that have changed the treatment landscape of HIV/AIDS, such as Truvada and Biktarvy. Lenapavir sodium is another major milestone achieved in its research and development of anti-HIV drugs, marking the world's entry into the "era of long-acting treatment."

Different from traditional HIV treatment drugs, the innovative mechanism of lenapavir sodium is that it is an HIV capsid inhibitor (Capsid Inhibitor). HIV capsid is an indispensable structure in the process of viral replication and assembly. Lenapavir sodium can exert an inhibitory effect on multiple stages of the virus life cycle by interfering with the assembly and disassembly of viral capsid proteins. This mechanism is different from previous reverse transcriptase inhibitors or protease inhibitors, and thus can provide a new treatment approach for patients with strong drug resistance.

In addition, the pharmacokinetic profile of lenapavir sodium is equally revolutionary. Its injection form is a long-acting sustained-release preparation, which can maintain stable drug concentration in the body for up to six months. This "half-yearly injection" model greatly reduces the patient's burden of daily medication, improves compliance, and reduces the risk of viral rebound caused by missed doses or irregular medication. For this reason, lenapavir sodium is considered a key step in the HIV treatment model from "controlling the virus" to "sustained suppression".

Gilead is promoting the registration of lenapavir sodium globally. Currently, the drug has been approved for marketing in the United States, the European Union, Japan and other countries. It is mainly used to treat patients with multidrug-resistant HIV-1 infection. Gilead's R&D system strictly follows international GMP standards to ensure drug quality and safety, laying a solid foundation for its global promotion.

Reference materials:https://www.drugs.com/sunlenca.html